India Coronavirus Dispatch: Syringe makers ramp up production capabilities

Scores of Keralites return home from abroad, why politicising health is a bad idea, how Mumbai plans to inoculate its frontline staff-news relevant to India's fight against Covid-19

Syringe makers ramp up production capabilities

As India inches closer towards kicking off the Covid-19 vaccination drive, syringe makers have been hard at work to ramp up production capabilities, according to a report in The Quint.

India's national drug regulator announced on January 3 that the Covid-19 vaccines of both Serum Institute of India (SII) and Bharat Biotech have been approved for emergency and restricted use in the country. The country is planning to begin the vaccination drive on January 13.

According to early estimates, about 1.80 billion syringes will be required just to inoculate at least 6 in 10 people in India.